| Code | Description | Claims | Beneficiaries | Total Paid |
|---|
| 87426 |
Infectious agent antigen detection, SARS-CoV-2 (COVID-19) |
3,755 |
3,491 |
$139K |
| 87635 |
Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe |
2,090 |
1,889 |
$79K |
| 88305 |
Level IV - Surgical pathology, gross and microscopic examination |
728 |
574 |
$42K |
| 87491 |
Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe |
1,882 |
1,121 |
$39K |
| 87591 |
Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe |
1,865 |
1,117 |
$39K |
| 88142 |
|
1,239 |
1,211 |
$23K |
| 87661 |
Infectious agent detection by nucleic acid; Trichomonas vaginalis, amplified probe |
873 |
491 |
$18K |
| 87624 |
Infectious agent detection by nucleic acid; human papillomavirus (HPV), high-risk types |
496 |
304 |
$11K |
| 88141 |
|
388 |
381 |
$10K |
| 87804 |
Infectious agent antigen detection by immunoassay; Influenza, each type |
297 |
291 |
$4K |
| 87807 |
|
339 |
335 |
$4K |
| 87631 |
|
14 |
12 |
$2K |
| 87563 |
|
14 |
13 |
$421.08 |
| 87481 |
|
14 |
13 |
$421.08 |
| 81513 |
|
15 |
13 |
$0.00 |